- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Ultrasound hurt by global recession, but Asia softens blow
Sales of ultrasound equipment fared better last year than those of other, more costly, imaging products such as MR and CT. The reason, according to InMedica, the medical research division of IMS Research, may be as simple as the price tag.
Sales of ultrasound equipment fared better last year than those of other, more costly, imaging products such as MR and CT. The reason, according to InMedica, the medical research division of IMS Research, may be as simple as the price tag. Pressed by budget concerns, buyers of new equipment in 2009 tended to purchase less expensive equipment. But that doesn’t mean ultrasound fared well.
The global market for ultrasound products shrank 6% last year to $4.9 billion compared with 2008, according to InMedica. The downturn was tied to cuts in healthcare spending and postponed equipment purchasing in Western Europe and North America. Market recovery will be slow, according to the company, due to continued economic uncertainty in Europe and further expected cuts in public health spending. These will prevent a return to growth until 2011.
Shortfalls in Western Europe and North America, however, were partly offset by strong growth in the developing markets of the Asia Pacific region, where increasing demand for ultrasound systems in 2009 came from greater investment in healthcare services. Demand for ultrasound systems has come particularly in China, India, and Southeast Asia, which are expected to continue to drive future market growth.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
